Unasyn Injection, Powder, For Solution
Product Images NDC 0049-0024

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Unasyn (NDC 0049-0024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Roerig, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Unasyn Bulk 01)

FDA Label Image

Chemical Structure (Unasyn Bulk 02)

FDA Label Image

Logo (Unasyn Bulk 03)

Logo (Unasyn Bulk 03)
This is a listing for a pharmaceutical product called "Injectables", which is distributed by Roerig, a division of Pfizer Inc, based in New York City. It is likely a medication administered through injection.*
FDA Label Image

Principal Display Panel (15 g Bulk Vial Label)

Principal Display Panel (15 g Bulk Vial Label)
This appears to be the label information of a prescription drug called Unasyn. Unasyn contains a combination of ampicillin and sulbactam sodium and is intended for intravenous use. The product comes in a sterile 15g container and is labeled with NDC number 0049-0024-28. The label also includes a product code 51744221 and a manufacturer location of New York, NY 10017.*
FDA Label Image

Principal Display Panel (15 g Bottle Carton)

Principal Display Panel (15 g Bottle Carton)
This is a description of a pharmacy bulk package of Unasyn, which contains ampicillin sodium and sulbactam sodium with a total volume of 15g. The package is not intended for direct infusion and requires reconstitution with sterile water. The recommended storage for the package is at or below 86°F (0°C). After reconstitution, the solution may be stored for up to 2 hours at room temperature and up to 4 hours if refrigerated. The solution should be discarded if its usage exceeds these time periods. It is advised to use aseptic technique for reconstitution and to transfer the solution to appropriate intravenous infusion devices under sterile conditions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.